Soldano Ferrone - Publications

Affiliations: 
New York Medical College, New York, NY, United States 
Area:
Immunology, Microbiology Biology
Website:
http://www.scirp.org/Conference/CommitteemanInfor.aspx?PersonID=9217

279 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Tian T, Lv X, Pan G, Lu Y, Chen W, He W, Lei X, Zhang H, Liu M, Sun S, Ou Z, Lin X, Cai L, He L, Tu Z, ... ... Ferrone S, et al. Long noncoding RNA MPRL promotes mitochondrial fission and cisplatin chemosensitivity via disruption of pre-miRNA processing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30885939 DOI: 10.1158/1078-0432.CCR-18-2739  0.44
2019 Du H, Hirabayashi K, Ahn S, Kren NP, Montgomery SA, Wang X, Tiruthani K, Mirlekar B, Michaud D, Greene K, Herrera SG, Xu Y, Sun C, Chen Y, Ma X, ... ... Ferrone S, et al. Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells. Cancer Cell. 35: 221-237.e8. PMID 30753824 DOI: 10.1016/j.ccell.2019.01.002  0.44
2019 Fan S, Tian T, Chen W, Lv X, Lei X, Zhang H, Sun S, Cai L, Pan G, He L, Ou Z, Lin X, Wang X, Perez MF, Tu Z, ... Ferrone S, et al. Mitochondrial miRNA determines chemoresistance by reprogramming metabolism and regulating mitochondrial transcription. Cancer Research. PMID 30659020 DOI: 10.1158/0008-5472.CAN-18-2505  0.44
2018 Zeng B, Liao J, Zhang H, Fu S, Chen W, Pan G, Li Q, Chen W, Ferrone S, Wu B, Sun S, Hu J, Ahn MH, Lin Z, Yu D, et al. Novel ANO5 mutation c.1067G>T (p.C356F) identified by whole genome sequencing in a big family with atypical gnathodiaphyseal dysplasia. Head & Neck. PMID 30554457 DOI: 10.1002/hed.25516  0.44
2018 Cai L, Michelakos T, Yamada T, Fan S, Wang X, Schwab JH, Ferrone CR, Ferrone S. Defective HLA class I antigen processing machinery in cancer. Cancer Immunology, Immunotherapy : Cii. PMID 29487978 DOI: 10.1007/s00262-018-2131-2  0.44
2017 Wang X, Wang X, Gu J, Zhou M, He Z, Wang X, Ferrone S. Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP. Oncotarget. 8: 113837-113846. PMID 29371950 DOI: 10.18632/oncotarget.22985  0.44
2017 Cong J, Wang Y, Zhang X, Zhang N, Liu L, Soukup K, Michelakos T, Hong T, DeLeo A, Cai L, Sabbatino F, Ferrone S, Lee H, Levina V, Fuchs B, et al. A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing Disulfiram. Cancer Letters. PMID 28864067 DOI: 10.1016/j.canlet.2017.08.028  0.44
2017 Wang X, Wang Y, Gu J, Zhou D, He Z, Wang X, Ferrone S. ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells. Scientific Reports. 7: 9687. PMID 28852196 DOI: 10.1038/s41598-017-10468-x  0.44
2017 Cai L, Michelakos T, Ferrone CR, Zhang L, Deshpande V, Shen Q, De Leo A, Yamada T, Zhang G, Ferrone S, Wang X. Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma. Oncotarget. PMID 28430580 DOI: 10.18632/oncotarget.16841  0.44
2016 Concha-Benavente F, Srivastava R, Ferrone S, Ferris RL. Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells. Oral Oncology. PMID 27264839 DOI: 10.1016/j.oraloncology.2016.05.008  0.44
2016 Sabbatino F, Wang Y, Scognamiglio G, Favoino E, Feldman SA, Villani V, Flaherty KT, Nota S, Giannarelli D, Simeone E, Anniciello AM, Palmieri G, Pepe S, Botti G, Ascierto PA, ... ... Ferrone S, et al. Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma. Journal of the National Cancer Institute. 108. PMID 26851802 DOI: 10.1093/jnci/djv435  0.32
2015 Schoenfeld AJ, Wang X, Wang Y, Hornicek FJ, Nielsen GP, Duan Z, Ferrone S, Schwab JH. CSPG4 as a prognostic biomarker in chordoma. The Spine Journal : Official Journal of the North American Spine Society. PMID 26689475 DOI: 10.1016/j.spinee.2015.11.059  0.44
2015 Ascierto PA, Atkins M, Bifulco C, Botti G, Cochran A, Davies M, Demaria S, Dummer R, Ferrone S, Formenti S, Gajewski TF, Garbe C, Khleif S, Kiessling R, Lo R, et al. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014. Journal of Translational Medicine. 13: 374. PMID 26619946 DOI: 10.1186/s12967-015-0736-1  0.44
2015 Wang Y, Wang X, Ferrone CR, Schwab JH, Ferrone S. Intracellular antigens as targets for antibody based immunotherapy of malignant diseases. Molecular Oncology. PMID 26597109 DOI: 10.1016/j.molonc.2015.10.019  0.44
2015 Tsao CY, Sabbatino F, Cheung NV, Hsu JC, Villani V, Wang X, Ferrone S. Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells. Oncoimmunology. 4: e1023975. PMID 26405581 DOI: 10.1080/2162402X.2015.1023975  0.44
2015 Chang CC, Pirozzi G, Wen SH, Chung IH, Chiu BL, Errico S, Luongo M, Lombardi ML, Ferrone S. Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy. The Journal of Biological Chemistry. PMID 26381407 DOI: 10.1074/jbc.M115.676130  0.44
2015 Jie HB, Schuler PJ, Lee SC, Srivastava RM, Argiris A, Ferrone S, Whiteside TL, Ferris RL. CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis. Cancer Research. 75: 2200-10. PMID 25832655 DOI: 10.1158/0008-5472.CAN-14-2788  0.44
2015 Surmann EM, Voigt AY, Michel S, Bauer K, Reuschenbach M, Ferrone S, von Knebel Doeberitz M, Kloor M. Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer. Cancer Immunology, Immunotherapy : Cii. 64: 357-66. PMID 25445815 DOI: 10.1007/s00262-014-1638-4  0.44
2014 Sabbatino F, Wang Y, Wang X, Schwab JH, Ferrone S, Ferrone CR. Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors. Seminars in Oncology. 41: 685-99. PMID 25440613 DOI: 10.1053/j.seminoncol.2014.08.007  0.44
2014 Ferrone S. Therapeutic monoclonal antibodies: introduction. Seminars in Oncology. 41: 556-8. PMID 25440602 DOI: 10.1053/j.seminoncol.2014.09.011  0.44
2014 Beard RE, Zheng Z, Lagisetty KH, Burns WR, Tran E, Hewitt SM, Abate-Daga D, Rosati SF, Fine HA, Ferrone S, Rosenberg SA, Morgan RA. Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells. Journal For Immunotherapy of Cancer. 2: 25. PMID 25197555 DOI: 10.1186/2051-1426-2-25  0.44
2014 Wang Y, Li W, Patel SS, Cong J, Zhang N, Sabbatino F, Liu X, Qi Y, Huang P, Lee H, Taghian A, Li JJ, DeLeo AB, Ferrone S, Epperly MW, et al. Blocking the formation of radiation-induced breast cancer stem cells. Oncotarget. 5: 3743-55. PMID 25003837  0.44
2014 Shen JK, Cote GM, Choy E, Yang P, Harmon D, Schwab J, Nielsen GP, Chebib I, Ferrone S, Wang X, Wang Y, Mankin H, Hornicek FJ, Duan Z. Programmed cell death ligand 1 expression in osteosarcoma. Cancer Immunology Research. 2: 690-8. PMID 24866169 DOI: 10.1158/2326-6066.CIR-13-0224  0.44
2014 Leone P, Di Tacchio M, Berardi S, Santantonio T, Fasano M, Ferrone S, Vacca A, Dammacco F, Racanelli V. Dendritic cell maturation in HCV infection: altered regulation of MHC class I antigen processing-presenting machinery. Journal of Hepatology. 61: 242-51. PMID 24732300 DOI: 10.1016/j.jhep.2014.04.007  0.44
2014 Sabbatino F, Wang Y, Wang X, Flaherty KT, Yu L, Pepin D, Scognamiglio G, Pepe S, Kirkwood JM, Cooper ZA, Frederick DT, Wargo JA, Ferrone S, Ferrone CR. PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation. Oncotarget. 5: 1926-41. PMID 24732172  0.44
2014 Gameiro SR, Jammeh ML, Wattenberg MM, Tsang KY, Ferrone S, Hodge JW. Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing. Oncotarget. 5: 403-16. PMID 24480782 DOI: 10.18632/oncotarget.1719  0.44
2014 Geldres C, Savoldo B, Hoyos V, Caruana I, Zhang M, Yvon E, Del Vecchio M, Creighton CJ, Ittmann M, Ferrone S, Dotti G. T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 962-71. PMID 24334762 DOI: 10.1158/1078-0432.CCR-13-2218  0.44
2014 Wang Y, Sabbatino F, Wang X, Ferrone S. Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma. Methods in Molecular Biology (Clifton, N.J.). 1102: 523-35. PMID 24258997 DOI: 10.1007/978-1-62703-727-3_28  0.44
2014 Fauci JM, Sabbatino F, Wang Y, Londoño-Joshi AI, Straughn JM, Landen CN, Ferrone S, Buchsbaum DJ. Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96. Gynecologic Oncology. 132: 203-10. PMID 24216048 DOI: 10.1016/j.ygyno.2013.10.038  0.44
2013 Sabbatino F, Schwab JH, Ferrone S, Ferrone CR. Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells. Clinical Transplants. 453-63. PMID 25095541  0.44
2013 Morandi B, Bonaccorsi I, Mesiti M, Conte R, Carrega P, Costa G, Iemmo R, Martini S, Ferrone S, Cantoni C, Mingari MC, Moretta L, Ferlazzo G. Characterization of human afferent lymph dendritic cells from seroma fluids Journal of Immunology. 191: 4858-4866. PMID 24078697 DOI: 10.4049/jimmunol.1300760  0.44
2013 Sabbatino F, Wang Y, Wang X, Ferrone S, Ferrone CR. Emerging BRAF inhibitors for melanoma. Expert Opinion On Emerging Drugs. 18: 431-43. PMID 24073999 DOI: 10.1517/14728214.2013.842975  0.44
2013 Ascierto PA, Grimaldi AM, Acquavella N, Borgognoni L, Calabrò L, Cascinelli N, Cesano A, Del Vecchio M, Eggermont AM, Faries M, Ferrone S, Fox BA, Gajewski TF, Galon J, Gnjatic S, et al. Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012". Journal of Translational Medicine. 11: 137. PMID 23731854 DOI: 10.1186/1479-5876-11-137  0.44
2013 Hamilton R, Krauze M, Romkes M, Omolo B, Konstantinopoulos P, Reinhart T, Harasymczuk M, Wang Y, Lin Y, Ferrone S, Whiteside T, Bortoluzzi S, Werley J, Nukui T, Fallert-Junecko B, et al. Pathologic and gene expression features of metastatic melanomas to the brain. Cancer. 119: 2737-46. PMID 23695963 DOI: 10.1002/cncr.28029  0.44
2013 Eisenberg G, Uzana R, Pato A, Frankenburg S, Merims S, Yefenof E, Ferrone S, Peretz T, Machlenkin A, Lotem M. Imprinting of lymphocytes with melanoma antigens acquired by trogocytosis facilitates identification of tumor-reactive T cells. Journal of Immunology (Baltimore, Md. : 1950). 190: 5856-65. PMID 23626012 DOI: 10.4049/jimmunol.1202879  0.44
2013 Srivastava RM, Lee SC, Andrade Filho PA, Lord CA, Jie HB, Davidson HC, López-Albaitero A, Gibson SP, Gooding WE, Ferrone S, Ferris RL. Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1858-72. PMID 23444227 DOI: 10.1158/1078-0432.CCR-12-2426  0.44
2013 Schilling B, Harasymczuk M, Schuler P, Egan J, Ferrone S, Whiteside TL. IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells. Plos One. 8: e47234. PMID 23408925 DOI: 10.1371/journal.pone.0047234  0.44
2013 Yeung JT, Hamilton RL, Ohnishi K, Ikeura M, Potter DM, Nikiforova MN, Ferrone S, Jakacki RI, Pollack IF, Okada H. LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1816-26. PMID 23401227 DOI: 10.1158/1078-0432.CCR-12-2861  0.44
2013 Hodge JW, Garnett CT, Farsaci B, Palena C, Tsang KY, Ferrone S, Gameiro SR. Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death. International Journal of Cancer. Journal International Du Cancer. 133: 624-36. PMID 23364915 DOI: 10.1002/ijc.28070  0.44
2013 Sabbatino F, Ferrone S. Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 958-60. PMID 23340298 DOI: 10.1158/1078-0432.CCR-12-3586  0.44
2013 Ferrone S. A tribute to Edgardo Carosella on the occasion of the 6th International Conference on HLA-G held in Paris, France, July 9-11, 2012. Human Immunology. 74: 405. PMID 23232062 DOI: 10.1016/j.humimm.2012.11.029  0.44
2013 Whiteside TL, Ferrone S. IGKC and prognosis in breast cancer--response to Schmidt. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 305. PMID 23231949 DOI: 10.1158/1078-0432.CCR-12-3200  0.44
2012 Fauci JM, Straughn JM, Ferrone S, Buchsbaum DJ. A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer. Gynecologic Oncology. 127: 420-5. PMID 22910694 DOI: 10.1016/j.ygyno.2012.08.017  0.44
2012 Rivera Z, Ferrone S, Wang X, Jube S, Yang H, Pass HI, Kanodia S, Gaudino G, Carbone M. CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5352-63. PMID 22893632 DOI: 10.1158/1078-0432.CCR-12-0628  0.44
2012 Ascierto PA, Grimaldi AM, Curti B, Faries MB, Ferrone S, Flaherty K, Fox BA, Gajewski TF, Gershenwald JE, Gogas H, Grossmann K, Hauschild A, Hodi FS, Kefford R, Kirkwood JM, et al. Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011". Journal of Translational Medicine. 10: 83. PMID 22551296 DOI: 10.1186/1479-5876-10-83  0.44
2012 Whiteside TL, Ferrone S. For breast cancer prognosis, immunoglobulin kappa chain surfaces to the top. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2417-9. PMID 22442060 DOI: 10.1158/1078-0432.CCR-12-0566  0.44
2012 Khoury T, Ademuyiwa FO, Chandrasekhar R, Chandraseekhar R, Jabbour M, Deleo A, Ferrone S, Wang Y, Wang X. Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 25: 388-97. PMID 22080062 DOI: 10.1038/modpathol.2011.172  0.44
2012 Liu Y, Komohara Y, Domenick N, Ohno M, Ikeura M, Hamilton RL, Horbinski C, Wang X, Ferrone S, Okada H. Expression of antigen processing and presenting molecules in brain metastasis of breast cancer. Cancer Immunology, Immunotherapy : Cii. 61: 789-801. PMID 22065046 DOI: 10.1007/s00262-011-1137-9  0.44
2011 Wang X, Katayama A, Wang Y, Yu L, Favoino E, Sakakura K, Favole A, Tsuchikawa T, Silver S, Watkins SC, Kageshita T, Ferrone S. Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4. Cancer Research. 71: 7410-22. PMID 22021902 DOI: 10.1158/0008-5472.CAN-10-1134  0.44
2011 Price MA, Colvin Wanshura LE, Yang J, Carlson J, Xiang B, Li G, Ferrone S, Dudek AZ, Turley EA, McCarthy JB. CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma. Pigment Cell & Melanoma Research. 24: 1148-57. PMID 22004131 DOI: 10.1111/j.1755-148X.2011.00929.x  0.44
2011 Ferrone S. Hidden immunotherapy targets challenge dogma. Science Translational Medicine. 3: 99ps38. PMID 21900591 DOI: 10.1126/scitranslmed.3002821  0.44
2011 Visus C, Wang Y, Lozano-Leon A, Ferris RL, Silver S, Szczepanski MJ, Brand RE, Ferrone CR, Whiteside TL, Ferrone S, DeLeo AB, Wang X. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6174-84. PMID 21856769 DOI: 10.1158/1078-0432.CCR-11-1111  0.44
2011 Morandi F, Corrias MV, Levreri I, Scaruffi P, Raffaghello L, Carlini B, Bocca P, Prigione I, Stigliani S, Amoroso L, Ferrone S, Pistoia V. Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients. Cancer Immunology, Immunotherapy : Cii. 60: 1485-95. PMID 21660451 DOI: 10.1007/s00262-011-1052-0  0.44
2011 Zarour HM, Ferrone S. Cancer immunotherapy: Progress and challenges in the clinical setting. European Journal of Immunology. 41: 1510-5. PMID 21618503 DOI: 10.1002/eji.201190035  0.44
2011 Campoli M, Ferrone S. HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition. Seminars in Immunopathology. 33: 321-34. PMID 21523560 DOI: 10.1007/s00281-011-0270-z  0.44
2011 Respa A, Bukur J, Ferrone S, Pawelec G, Zhao Y, Wang E, Marincola FM, Seliger B. Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 2668-78. PMID 21248298 DOI: 10.1158/1078-0432.CCR-10-2114  0.32
2011 Brady MT, Lee J, Ferrone S, Wang ES, Wetzler M. Interferon-γ secretion by t(9;22) acute lymphoblastic leukemia-derived dendritic cells. Leukemia Research. 35: 275-7. PMID 20943267 DOI: 10.1016/j.leukres.2010.09.003  0.44
2011 Sconocchia G, Zlobec I, Lugli A, Calabrese D, Iezzi G, Karamitopoulou E, Patsouris ES, Peros G, Horcic M, Tornillo L, Zuber M, Droeser R, Muraro MG, Mengus C, Oertli D, ... Ferrone S, et al. Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. International Journal of Cancer. Journal International Du Cancer. 128: 2663-72. PMID 20715106 DOI: 10.1002/ijc.25609  0.44
2010 Campoli M, Ferrone S, Wang X. Functional and clinical relevance of chondroitin sulfate proteoglycan 4. Advances in Cancer Research. 109: 73-121. PMID 21070915 DOI: 10.1016/B978-0-12-380890-5.00003-X  0.44
2010 Wang X, Osada T, Wang Y, Yu L, Sakakura K, Katayama A, McCarthy JB, Brufsky A, Chivukula M, Khoury T, Hsu DS, Barry WT, Lyerly HK, Clay TM, Ferrone S. CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer. Journal of the National Cancer Institute. 102: 1496-512. PMID 20852124 DOI: 10.1093/jnci/djq343  0.44
2010 Burns WR, Zhao Y, Frankel TL, Hinrichs CS, Zheng Z, Xu H, Feldman SA, Ferrone S, Rosenberg SA, Morgan RA. A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas. Cancer Research. 70: 3027-33. PMID 20395199 DOI: 10.1158/0008-5472.CAN-09-2824  0.44
2010 Cairo MS, Jordan CT, Maley CC, Chao C, Melnick A, Armstrong SA, Shlomchik W, Molldrem J, Ferrone S, Mackall C, Zitvogel L, Bishop MR, Giralt SA, June CH. NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 709-28. PMID 20227509 DOI: 10.1016/j.bbmt.2010.03.002  0.44
2010 Karyampudi L, Formicola C, Erskine CL, Maurer MJ, Ingle JN, Krco CJ, Wettstein PJ, Kalli KR, Fikes JD, Beebe M, Hartmann LC, Disis ML, Ferrone S, Ishioka G, Knutson KL. A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 825-34. PMID 20103660 DOI: 10.1158/1078-0432.CCR-09-2781  0.44
2010 Campoli M, Ferris R, Ferrone S, Wang X. Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 11-20. PMID 20028761 DOI: 10.1158/1078-0432.CCR-09-2345  0.44
2010 Cathro HP, Smolkin ME, Theodorescu D, Jo VY, Ferrone S, Frierson HF. Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas. Cancer Immunology, Immunotherapy : Cii. 59: 465-72. PMID 19756593 DOI: 10.1007/s00262-009-0765-9  0.44
2010 Ferris RL, Ferrone S. Response to the letter to the editors by Ottaiano et al.: "Cetuximab-dependent ADCC in cancer: Dream or reality?" Cancer Immunology, Immunotherapy. 59: 1609-1610. DOI: 10.1007/s00262-010-0885-2  0.44
2008 Campoli M, Ferrone S. HLA antigen changes in malignant cells: Epigenetic mechanisms and biologic significance Oncogene. 27: 5869-5885. PMID 18836468 DOI: 10.1038/onc.2008.273  0.44
2008 Campoli M, Ferrone S. Tumor escape mechanisms: Potential role of soluble HLA antigens and NK cells activating ligands Tissue Antigens. 72: 321-334. PMID 18700879 DOI: 10.1111/j.1399-0039.2008.01106.x  0.44
2008 Campoli M, Ferrone S. Anti-inflammatory biologic therapies and immune surveillance of melanoma Expert Review of Dermatology. 3: 129-131. DOI: 10.1586/17469872.3.2.129  0.44
2008 Seliger B, Ferrone S. HLA class I antigen abnormalities in tumors General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology. 123-144. DOI: 10.1007/978-1-4020-6087-8_6  0.44
2007 Ferrone S, Whiteside TL. Tumor Microenvironment and Immune Escape Surgical Oncology Clinics of North America. 16: 755-774. PMID 18022543 DOI: 10.1016/j.soc.2007.08.004  0.44
2007 Chang CC, Ferrone S. Immune selective pressure and HLA class I antigen defects in malignant lesions Cancer Immunology, Immunotherapy. 56: 227-236. PMID 16783578 DOI: 10.1007/s00262-006-0183-1  0.44
2006 Chang CC, Ferrone S. NK cell activating ligands on human malignant cells: Molecular and functional defects and potential clinical relevance Seminars in Cancer Biology. 16: 383-392. PMID 16931041 DOI: 10.1016/j.semcancer.2006.07.001  0.44
2006 Bangia N, Ferrone S. Antigen presentation machinery (APM) modulation and soluble HLA molecules in the tumor microenvironment: do they provide tumor cells with escape mechanisms from recognition by cytotoxic T lymphocytes? Immunological Investigations. 35: 485-503. PMID 16916763 DOI: 10.1080/08820130600808246  0.44
2006 Ferrone S, Ko E. Collaboration is required for successful immunotherapy Blood. 107: 3025-3026. DOI: 10.1182/blood-2006-01-0424  0.44
2006 Bankert R, Ferrone S. Immunological Investigations: Introduction Immunological Investigations. 35: 249-250. DOI: 10.1080/08820130600840686  0.44
2006 Reynolds SR, Ferrone S, Bystryn JC. Response to: Circulating tumor cells and detection of melanoma-associated antigen HMW-MAA in the serum of melanoma patients [3] Journal of Investigative Dermatology. 126: 916. DOI: 10.1038/sj.jid.5700156  0.44
2005 Ferris RL, Hunt JL, Ferrone S. Human leukocyte antigen (HLA) class I defects in head and neck cancer: Molecular mechanisms and clinical significance Immunologic Research. 33: 113-133. PMID 16234579 DOI: 10.1385/IR:33:2:113  0.44
2005 Kawano K, Ferrone S, Ioannides CG. Functional idiotopes: tumor antigen-directed expression of CD8+ T-cell epitopes nested in unique NH2-terminal VH sequence of antiidiotypic antibodies? Cancer Research. 65: 6001-4. PMID 16024597 DOI: 10.1158/0008-5472.CAN-04-3400  0.44
2005 Chang CC, Campoli M, Ferrone S. Classical and nonclassical HLA class I antigen and NK cell-activating ligand changes in malignant cells: Current challenges and future directions Advances in Cancer Research. 93: 189-234. PMID 15797448 DOI: 10.1016/S0065-230X(05)93006-6  0.44
2005 Ferrone S, Sconocchia G. A clinically relevant mouse model of human multiple myeloma? Blood. 106: 388-389. DOI: 10.1182/blood-2005-04-1676  0.44
2005 Whiteside TL, Campoli M, Ferrone S. Immune escape: Tumor induced immune suppression and immune escape: Mechanisms and possible solutions Analyzing T Cell Responses: How to Analyze Cellular Immune Responses Against Tumor Associated Antigens. 43-81. DOI: 10.1007/1-4020-3623-X_3  0.44
2004 Ferrone S. Immunotherapy dispenses with tumor antigens Nature Biotechnology. 22: 1096-1098. PMID 15340476 DOI: 10.1038/nbt0904-1096  0.44
2004 Campoli M, Ferrone S. T-cell-based immunotherapy of melanoma: What have we learned and how can we improve? Expert Review of Vaccines. 3: 171-187. PMID 15056043 DOI: 10.1586/14760584.3.2.171  0.44
2003 Marincola FM, Ferrone S. Immunotherapy of melanoma: The good news, the bad ones and what to do next Seminars in Cancer Biology. 13: 387-389. PMID 15001156 DOI: 10.1016/j.semcancer.2003.09.002  0.44
2003 Chang CC, Ferrone S. HLA-G in melanoma: Can the current controversies be solved? Seminars in Cancer Biology. 13: 361-369. PMID 14708716 DOI: 10.1016/S1044-579X(03)00027-0  0.44
2003 Chang CC, Murphy SP, Ferrone S. Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms. Human Immunology. 64: 1057-63. PMID 14602236 DOI: 10.1016/j.humimm.2003.08.357  0.44
2003 Wang X, Liang B, Rebmann V, Lu J, Celis E, Kageshita T, Grosse-Wilde H, Ferrone S. Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2. Tissue Antigens. 62: 139-48. PMID 12889994  0.44
2002 Ferrone S. Changes in serum ganglioside and antibody levels in soft tissue sarcoma: Are they the cause or the effect of tumor progression? Cancer Journal. 8: 369-370. PMID 12416893 DOI: 10.1097/00130404-200209000-00006  0.44
2002 Noronha EJ, Wang X, Ferrone S. Isolation of human tumor-associated cell surface antigen-binding scFvs Methods in Molecular Biology (Clifton, N.J.). 178: 227-233. PMID 11968492  0.44
2002 Ferrone S. Tumor escape mechanism: Introduction Seminars in Cancer Biology. 12: 1-2. DOI: 10.1006/scbi.2001.0396  0.44
2001 Ferrone S, Wang X. Active specific immunotherapy of malignant melanoma and peptide mimics of the human high-molecular-weight melanoma-associated antigen Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 158: 231-235. PMID 11092050  0.44
1997 Natali PG, Hamby CV, Felding-Habermann B, Liang B, Nicotra MR, Di Filippo F, Giannarelli D, Temponi M, Ferrone S. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Research. 57: 1554-60. PMID 9108459  0.44
1996 Reisfeld RA, Ferrone S. International Conference on the Biology of Melanoma, Aviano, Italy, 24-26 September 1995 Melanoma Research. 6: 447-456. PMID 9013483 DOI: 10.1097/00008390-199612000-00007  0.44
1996 Hicklin DJ, Kageshita T, Ferrone S. Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing Tissue Antigens. 48: 38-46. PMID 8864173  0.44
1996 Ferrone S. Anti-idiotypic monoclonal antibodies as therapeutic vaccines Melanoma Research. 6: 179. PMID 8791277  0.44
1995 Kageshita T, Hirai S, Ono T, Ferrone S. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic MAb MK2-23. Immunohistochemical analysis of the reactivity of anti-anti-idiotypic MAb with surgically removed melanoma lesions International Journal of Cancer. 60: 334-340. PMID 7829240  0.44
1995 Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevance Immunology Today. 16: 487-494. PMID 7576053 DOI: 10.1016/0167-5699(95)80033-6  0.44
1995 Arkin S, Ferrone S, Lipton JM. Modulation of adhesion molecule CD54 expression on CD34+ hematopoietic progenitors Experimental Hematology. 23: 588-596. PMID 7541368  0.44
1994 Ferrone S. Melanoma, immune surveillance, and immunotherapy Journal of Clinical Investigation. 93: 1351-1352. PMID 8163637  0.44
1993 Quagliata F, Schenkelaars EJ, Ferrone S. Immunotherapeutic approach to rheumatoid arthritis with anti-idiotypic antibodies to HLA-DR4 Israel Journal of Medical Sciences. 29: 154-159. PMID 8468170  0.44
1993 Armandola EA, Mariani SM, Ferrone S. Serological and molecular characterization of mouse anti-idiotypic monoclonal antibodies elicited with the syngeneic Anti-HLA-A2,28 monoclonal antibody CR11-351 Molecular Immunology. 30: 287-300. PMID 8433707 DOI: 10.1016/0161-5890(93)90057-I  0.44
1993 Chen ZJ, Ferrone S. Comparison of the binding parameters to melanoma cells of antihuman high molecular weight-melanoma associated antigen (HMW-MAA) monoclonal antibodies (mAb) and syngeneic Anti-Anti-idiotypic (Anti-Anti-id) mAb Annals of the New York Academy of Sciences. 690: 398-401. PMID 8368768  0.44
1993 Ferrone S. Human tumor-associated antigen mimicry by anti-idiotypic antibodies. Immunogenicity and clinical trials in patients with solid tumors Annals of the New York Academy of Sciences. 690: 214-224. PMID 8368740  0.44
1993 Ferrone S. Anti-idiotypes in Melanoma Hybridoma. 12: 509-514. PMID 8300123  0.44
1993 Ferrone S, Kageshita T, Hirai S. Active specific immunotherapy of malignant melanoma with anti-idiotypic monoclonal antibodies Journal of Dermatology. 20: 533-539. PMID 8227707  0.44
1993 Wang Z, Tatake RJ, Yang SY, Hu XZ, Zeff RA, Ferrone S. Differential Effect of Human and Mouse β2-Microglobulin on the Induction and the Antigenic Profile of Endogenous HLA-A and -B Antigens Synthesized by β2-Microglobulin Gene-null FO-1 Melanoma Cells Cancer Research. 53: 4303-4309. PMID 7689931  0.44
1993 Mariani SM, Armandola EA, Ferrone S. Preferential selection of a subset of Anti-HLA-DR monoclonal antibodies by a syngeneic anti-idiotypic monoclonal antibody Transplantation. 55: 1176-1181. PMID 7684538  0.44
1993 Ferrone S, Dupont B. Editorial Tissue Antigens. 42: 1.  0.44
1993 Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance Trends in Neurosciences. 16: 487-494.  0.44
1992 Cozzi E, Ferrone S. Immunotherapeutic approaches with monoclonal antibodies to immunological diseases Recenti Progressi in Medicina. 83: 528-533. PMID 1439123  0.44
1992 Tatake RJ, Ferrone S, Zeff RA. The role of beta-2 microglobulin in temperature-sensitive and interferon-γ-induced exocytosis of HLA class I molecules Transplantation. 54: 395-403. PMID 1412716  0.44
1992 Temponi M, Ferrone S, Gold AM. Binding Parameters and Idiotypic Profile of the Whole Immunoglobulin and Fab' Fragments of Murine Monoclonal Antibody to Distinct Determinants of the Human High Molecular Weight-Melanoma Associated Antigen Cancer Research. 52: 2497-2503. PMID 1373670  0.44
1992 Mariani SM, Armandola EA, Ferrone S. Diversity of anti-HLA-DR antibodies elicited by distinct anti-idiotypic monoclonal antibodies recognizing idiotopes co-expressed by the immunizing monoclonal antibody Immunology. 77: 597-603. PMID 1283602  0.44
1992 Mariani SM, Armandola EA, Ferrone S. Heterogeneity in the Anti-HLA-DR immune response elicited by the antiidiotype monoclonal antibody F5-444: Analysis at the clonal level Transplantation. 54: 1078-1084. PMID 1281563  0.44
1991 Mariani SM, Armandola EA, Ferrone S. Diversity in the fine specificity of anti-HLA-DR monoclonal antibodies elicited with syngeneic antiidiotypic monoclonal antibodies Transplantation Proceedings. 23: 455-456. PMID 1990583  0.44
1991 Hayashibe K, Mishima Y, Ferrone S. Cloning and in vitro expression of a melanoma-associated antigen immunogenic in patients with melanoma Journal of Immunology. 147: 1098-1104. PMID 1861072  0.44
1991 Chen ZJ, Yang H, Ferrone S. Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23: Characterization of the immunogenicity in syngeneic hosts Journal of Immunology. 147: 1082-1090. PMID 1861071  0.44
1991 Perosa F, Ferrone S, Dammacco F. Anti-idiotypic monoclonal antibodies reacting with idiotope on isolated-denatured chains of an anti-CD4 monoclonal antibody Immunology. 74: 748-750. PMID 1783432  0.44
1991 Mariani SM, Armandola EA, Ferrone S. Diversity in the fine specificity and idiotypic profile of mouse anti-HLA-DR monoclonal antibody elicited with the syngeneic anti-idiotypic monoclonal antibody F5-830 Journal of Immunology. 147: 1322-1330. PMID 1714480  0.44
1991 Coli A, Bigotti G, Ferrone S. Histiocytosis X arising in Hodgkin's disease: immunophenotypic characterization with a panel of monoclonal antibodies Virchows Archiv a Pathological Anatomy and Histopathology. 418: 369-373. PMID 1708928 DOI: 10.1007/BF01600168  0.44
1991 Shoenfeld Y, Ferrone S, Bombardieri S. New aspects in the treatment of immunomediated diseases Clinical and Experimental Rheumatology. 9: 663-673. PMID 1684923  0.44
1990 Temponi M, Pupa S, Ferrone S. Purification of immunoreactive radiolabeled monoclonal antibodies with anti-idiotypic monoclonal antibodies Journal of Immunological Methods. 126: 223-229. PMID 2406347 DOI: 10.1016/0022-1759(90)90154-N  0.44
1990 Shinji T, Ono R, Ferrone S. Fine specificity and idiotype diversity of a murine anti-HLA-DQw3 monoclonal antibody elicited with a syngeneic antiidiotypic monoclonal antibody Journal of Immunology. 144: 4291-4297. PMID 2341722  0.44
1990 Ferrone S. Monoclonal antibodies and tumor vaccines Current Opinion in Oncology. 2: 1146-1151. PMID 2099845  0.44
1989 Ono R, Sakaguchi K, Ferrone S. Modulation by antiidiotypic monoclonal antibodies of immune lysis mediated by anti-HLA monoclonal antibodies Journal of Immunology. 143: 1921-1929. PMID 2528584  0.44
1989 Maio M, Gulwani B, Tombesi S, Ferrone S. Modulation by cytokines of HLA antigens, intercellular adhesion molecule 1 and high molecular weight melanoma associated antigen expression and of immune lysis of clones derived from the melanoma cell line MeM 50-10 Cancer Immunology Immunotherapy. 30: 34-42. PMID 2513111 DOI: 10.1007/BF01665028  0.44
1989 Ziai MR, Ferrone S. Specific phosphorylation by calcium-egta complex of a 75kda human tumor plasma membrane protein (pp75) International Journal of Biochemistry. 21: 731-738. PMID 2503405 DOI: 10.1016/0020-711X(89)90203-6  0.44
1989 Graf LH, Ferrone S. Human melanoma-associated antigens Immunology Series. 43: 643-679. PMID 2490510  0.44
1989 Perosa F, Ferrone S. Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities Journal of Clinical Investigation. 84: 907-914. PMID 2474577  0.44
1988 Milo GE, Casto B, Ferrone S. Comparison of features of carcinogen-transformed human cells in vitro with sarcoma-derived cells Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 199: 387-398. PMID 3374509 DOI: 10.1016/0027-5107(88)90216-3  0.44
1988 Perosa F, Ferrone S. Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA-DR,DP monoclonal antibody CR11-462 Human Immunology. 23: 255-269. PMID 3266207 DOI: 10.1016/0198-8859(88)90061-4  0.44
1988 Temponi M, Kekish U, Ferrone S. Immunoreactivity and affinity of murine IgG monoclonal antibodies purified by caprylic acid precipitation Journal of Immunological Methods. 115: 151-152. PMID 3192945 DOI: 10.1016/0022-1759(88)90323-7  0.44
1988 Ferrone S, Kageshita T. Human high molecular weight-melanoma associated antigen as a target for active specific immunotherapy. A phase I clinical trial with murine antiidiotypic monoclonal antibodies Journal of Dermatology. 15: 457-465. PMID 3074088  0.44
1987 Perosa F, Ferrone S. Syngeneic anti-idiotypic antisera to murine anti-HLA Class II monoclonal antibodies Journal of Immunology. 139: 1232-1239. PMID 3611788  0.44
1987 Matsui M, Temponi M, Ferrone S. Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon Journal of Immunology. 139: 2088-2095. PMID 3114385  0.44
1987 Igarashi M, Suciu-Foca N, Ferrone S. Differential expression of HLA-DR allospecificities on antigen specific T cell clones Tissue Antigens. 29: 160-167. PMID 2440145  0.44
1987 Perosa F, Tsujisaki M, Ferrone S. Syngeneic anti-idiotypic antisera to murine monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens Journal of Immunology. 138: 2202-2207. PMID 2435792  0.44
1986 Van Duinen SG, Ruiter DJ, Ferrone S. Associated expression of HLA class I and class II antigens on melanoma cells in surgically removed metastases Journal of Pathology. 149: 339-348. PMID 3531448  0.44
1986 Quagliata F, Ferrone S, Taranta A. In vivo and in vitro antiinflammatory and immunoregulating properties of streptococcal mitogen: Effects on adjuvant disease in the rat, on homograft rejection in the mouse, and on the appearance of Ia antigens on human T lymphocytes Agents and Actions. 17: 377-378. PMID 3485892 DOI: 10.1007/BF01982653  0.44
1986 Giacomini P, Aguzzi A, Ferrone S. Differential susceptibility to modulation by recombinant immune interferon of HLA-DR and -DQ antigens synthesized by melanoma COLO 38 cells Hybridoma. 5: 277-288. PMID 3100420  0.44
1986 Ruiter DJ, Brocker EB, Ferrone S. Expression and susceptibility to modulation by interferons of HLA class I and II antigens on melanoma cells. Immunohistochemical analysis and clinical relevance Journal of Immunogenetics. 13: 229-234. PMID 2434574  0.44
1986 Ferrone S, Fukusato T, Gerber MA. Class I and Class II HLA antigens in colorectal and liver carcinomas Gann Monographs On Cancer Research. 75-83.  0.44
1985 Quagliata F, Ferrone S, Taranta A. In vivo and in vitro immunomodulatory ability of streptococcal mitogen: Effects on adjuvant disease in the rat; on homograft rejection in the mouse; and on the appearance of Ia antigens on human T lymphocytes Drugs Under Experimental and Clinical Research. 11: 75-81. PMID 3915283  0.44
1985 Ziai MR, Imberti L, Ferrone S. An enzyme-linked double antibody immunoassay to measure murine immunoglobulins - Its application to determine the specific activity of radiolabeled monoclonal antibodies Journal of Immunological Methods. 82: 233-241. PMID 3876390 DOI: 10.1016/0022-1759(85)90355-2  0.44
1985 Quagliata F, Ferrone S. Appearance of Ia antigens on T lymphocytes stimulated by streptococcal mitogen as an in vitro model of autoimmunity International Journal of Tissue Reactions. 7: 47-53. PMID 3874185  0.44
1985 Giacomini P, Natali P, Ferrone S. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants Journal of Immunology. 135: 696-702. PMID 2582052  0.44
1984 Glassy MC, Ferrone S. Ia antigen expression is increased on tunicamycin-resistant human B-lymphoid cells Clinical Immunology and Immunopathology. 32: 90-100. PMID 6610518 DOI: 10.1016/0090-1229(84)90046-1  0.44
1984 Russo C, Pellegrino MA, Ferrone S. Analysis of the repertoire of anti-HLA antibodies with anti-idiotypes to a murine anti-HLA-A2,A28 monoclonal antibody Human Immunology. 10: 57-67. PMID 6609912 DOI: 10.1016/0198-8859(84)90085-5  0.44
1984 Fitchen JH, Russo C, Ferrone S. Complement-dependent killing of human hematopoietic progenitor cells with noncomplement-fixing monoclonal antibodies in an antiglobulin assay Blood. 63: 873-877. PMID 6584186  0.44
1984 Lordon RE, Stelzer GT, Ferrone S. The early posttransplant prognosis of acute renal allograft rejection as determined by detection of cytotoxic antibodies to lymphoid B cell lines Transplantation. 38: 493-496. PMID 6388071  0.44
1984 Spooner RL, Ferrone S. Cross-reaction of monoclonal antibodies to human MHC class I and class II products with bovine lymphocyte subpopulations Tissue Antigens. 24: 270-277. PMID 6334909  0.44
1984 Zweig SE, Ferrone S, Shevach EM. Monoclonal antibodies directed against human Ia antigens detect an evolutionary conserved epitope on guinea pig Ia antigens with unique functional properties Journal of Leukocyte Biology. 35: 101-113. PMID 6200553  0.44
1984 Giacomini P, Aguzzi A, Ferrone S. Changes in synthesis and expression of MHC antigens induced by recombinant immune interferon (IFN-γ) in human melanoma cells Federation Proceedings. 43.  0.44
1983 Giacomini P, Natali PG, Ng AK, Kantor RRS, Ferrone S. Double determinant immunoassay to measure a human high-molecular-weight melanoma-associated antigen Cancer Research. 43: 3586-3590. PMID 6344987  0.44
1983 Ng AK, Giacomini P, Ferrone S. Monoclonal antibodies and immunologic approaches to malignant tumors Advances in Internal Medicine. 28: 253-276. PMID 6340428  0.44
1983 Indiveri F, Pierri I, Viglione D, Pende D, Russo C, Pellegrino MA, Ferrone S. Human T lymphocytes in aging and malignancy: Abnormalities in PHA-induced Ia antigen expression and in functional activity in autologous and allogeneic MLR Cellular Immunology. 76: 224-231. PMID 6220809 DOI: 10.1016/0008-8749(83)90365-9  0.44
1983 Wilson BS, Ruberto G, Ferrone S. Immunochemical characterization of a human high molecular weight - melanoma associated antigen identified with monoclonal antibodies Cancer Immunology Immunotherapy. 14: 196-201. PMID 6188530 DOI: 10.1007/BF00205360  0.44
1983 Imai K, Wada T, Ferrone S. Potential usefulness of the monoclonal antibodies to human melanoma-associated antigens Clinical Immunology Newsletter. 4: 74-78. DOI: 10.1016/S0197-1859(83)80003-X  0.44
1983 Russo C, Pellegrino MA, Ferrone S. A double-determinant immunoassay to quantitate human Ia antigens Transplantation Proceedings. 15: 57-59.  0.44
1983 Russo C, Pellegrino MA, Ferrone S. A double-determinant immunoassay with monoclonal antibodies to the HLA-A,B,C complex Transplantation Proceedings. 15: 66-68.  0.44
1982 Allen RW, Ferrone S, Hoch JA. Characterization of antigens on human lymphocytes coded by messenger RNA translated in vitro Molecular Immunology. 19: 1127-1138. PMID 7144756 DOI: 10.1016/0161-5890(82)90323-6  0.44
1982 Fitchen JH, Hays EF, Ferrone S. Expression of the H-2 antigenic complex on murine haematopoietic stem cells Scandinavian Journal of Immunology. 15: 547-551. PMID 6981838  0.44
1982 Wolf PL, Ferrone S. A radioimmunoassay and biological profile of Ia-like antigens on human melanoma cells Clinical Biochemistry. 15: 24-27. PMID 6978202 DOI: 10.1016/S0009-9120(82)90367-8  0.44
1981 Galloway DR, Imai K, Ferrone S, Reisfeld RA. Molecular profiles of human melanoma-associated antigens Federation Proceedings. 40: 231-236. PMID 7461145  0.44
1981 Galloway DR, McCabe RP, Pellegrino MA, Ferrone S, Reisfeld RA. Tumor-associated antigens in spent medium of human melanoma cells: Immunochemical characterization with xenoantisera Journal of Immunology. 126: 62-66. PMID 7451981  0.44
1981 Curry RA, Quaranta V, Pellegrino MA, Ferrone S. Lysis of Cultured Human Melanoma M10 Cells by Polyclonal Xenoantibodies to Melanoma-associated Antigens Cancer Research. 41: 463-466. PMID 7448792  0.44
1981 Pellegrino MA, Richiardi P, Ferrone S. 8th International Histocompatibility Workshop analysis of a goat antiserum to HLA-B15 allospecificity Tissue Antigens. 17: 542-545. PMID 7336416  0.44
1981 Nathanson SD, Pellegrino MA, Ferrone S. Serum HLA-A and B alloantigens in patients with malignant melanoma Transplantation Proceedings. 13: 1939-1941. PMID 7330977  0.44
1981 Wilson BS, Ruberto G, Ferrone S. Sulfation and molecular weight of fibronectin shed by human melamona cells Biochemical and Biophysical Research Communications. 101: 1047-1051. PMID 7306108 DOI: 10.1016/0006-291X(81)91854-4  0.44
1981 Natali PG, Quaranta V, Nicotra MR, Apollonj C, Pellegrino MA, Ferrone S. Tissue distribution of Ia-like antigens in different species: Analysis with monoclonal antibodies Transplantation Proceedings. 13: 1026-1029. PMID 7022914  0.44
1981 Natali PG, De Martino C, Quaranta V, Nicotra MR, Frezza F, Pellegrino MA, Ferrone S. Expression of Ia-like antigens in normal human nonlymphoid tissues Transplantation. 31. PMID 7015604  0.44
1981 Wilson BS, Ferrone S. Antibodies to human Ia-like antigens and heterologous anti-human lymphocyte sera Journal of Immunogenetics. 8: 1-5. PMID 6972978  0.44
1981 Glassy MC, Ferrone S. Ultrastructural alterations in human lymphoblastoid B cell lines treated with tunicamycin American Journal of Pathology. 103: 1-9. PMID 6971575  0.44
1981 Indiveri F, Pellegrino MA, Quaranta V, Molinaro GA, Ferrone S. Monoclonal and polyclonal xenoantibodies to the HLA-A, B, C antigenic molecular complex do not affect the functional activity of C3 receptors Immunobiology. 158: 17-21. PMID 6782009 DOI: 10.1016/S0171-2985(80)80031-3  0.44
1981 Russo C, Indiveri F, Quaranta V, Molinaro GA, Pellegrino MA, Ferrone S. Stimulation of human T lymphocytes by PHA-activated autologous T lymphocytes: Analysis of the role of Ia-like antigens with monoclonal antibodies Immunogenetics. 12: 267-274. PMID 6451578 DOI: 10.1007/BF01561669  0.44
1981 Quaranta V, Pellegrino MA, Ferrone S. The monoclonal xenoantibody Q6/64 recognizes a determinant expressed by certain gene products of the A and B loci of the HLA region Immunogenetics. 14: 403-413. PMID 6174438 DOI: 10.1007/BF00373320  0.44
1981 Indiveri F, Russo C, Quaranta V, Pellegrino MA, Ferrone S. HLA-DR antigens and mitogenic factors released by PWM-stimulated T lymphocytes share the framework determinant recognized by the monoclonal antibody Q5/13 Cellular Immunology. 62: 406-411. PMID 6169455 DOI: 10.1016/0008-8749(81)90341-5  0.44
1981 Quaranta V, Pellegrino MA, Callahan GN, Ferrone S. Cross-reactivity between human and murine lymphocyte antigens - IV. Reactivity of H-2 alloantisera with HLA-A, B antigens Immunogenetics. 13: 311-317. PMID 6168581 DOI: 10.1007/BF00364496  0.44
1981 Quaranta V, Walker LE, Ruberto G, Pellegrino MA, Ferrone S. The free and the β2-microglobulin-associated heavy chains of HLA-A, B alloantigens share the antigenic determinant recognized by the monoclonal antibody Q1/28 Immunogenetics. 13: 285-295. PMID 6168579 DOI: 10.1007/BF00364494  0.44
1981 Imai K, Ng AK, Ferrone S. Characterization of monoclonal antibodies to human melanoma-associated antigens Journal of the National Cancer Institute. 66: 489-496. PMID 6162991 DOI: 10.1093/jnci/66.3.489  0.44
1981 Quaranta V, Tanigaki N, Ferrone S. Distribution of antigenic determinants recognized by three monoclonal antibodies (Q2/70, Q5/6 and Q5/13) on human Ia-like alloantigens and on their subunits Immunogenetics. 12: 175-182. PMID 6162791 DOI: 10.1007/BF01561660  0.44
1981 Imai K, Galloway DR, Ferrone S. Serological and Immunochemical Analysis of the Specificity of Xenoantiserum 8986 Elicited with Hybrids Between Human Melanoma Cells and Murine Fibroblasts Cancer Research. 41: 1028-1033. PMID 6161692  0.44
1981 Quaranta V, Pellegrino MA, Ferrone S. Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens Journal of Immunology. 126: 548-552. PMID 6161181  0.44
1980 Ng AK, Indiveri F, Pellegrino MA, Molinaro GA, Quaranta V, Ferrone S. Natural cytotoxicity and antibody-dependent cellular cytotoxicity of human lymphocytes depleted of HLA-DR bearing cells with monoclonal HLA-DR antibodies Journal of Immunology. 124: 2336-2340. PMID 7365259  0.44
1980 Imai K, Molinaro GA, Ferrone S. Monoclonal antibodies to human melanoma-associated antigens Transplantation Proceedings. 12: 380-383. PMID 7222216  0.44
1980 Walker LE, Ferrone S, Pellegrino MA, Reisfeld RA. Structural polymorphism of the β chain of human HLA-DR antigens Molecular Immunology. 17: 1443-1448. PMID 6975425 DOI: 10.1016/0161-5890(80)90169-8  0.44
1980 Ades EW, Ferrone S, Balch CM. Immunochemical characterization of a human B lymphocyte differentiation antigen (p65) Scandinavian Journal of Immunology. 12: 519-523. PMID 6972571  0.44
1980 Imai K, Ferrone S. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera Cancer Research. 40: 2252-2256. PMID 6966965  0.44
1980 Russo C, Indiveri F, Quaranta V, Molinaro GA, Pellegrino MA, Ferrone S. Use of monoclonal antibodies to investigate immunologic cross-reactivity of histocompatibility antigens from various animal species Transplantation Proceedings. 12: 376-379. PMID 6784298  0.44
1980 Ferrone S, Pellegrino MA, Callahan GN. Human and murine tumours: Changes in cell surface structures coded by the major histocompatibility complex region Journal of Immunogenetics. 7: 71-79. PMID 6768809  0.44
1980 Indiveri F, Wilson BS, Russo C, Quaranta V, Pellegrino MA, Ferrone S. Ia-like antigens on human T lymphocytes: Relationship to other surface markers, role in mixed lymphocyte reactions, and structural profile Journal of Immunology. 125: 2673-2678. PMID 6448901  0.44
1980 Russo C, Quaranta V, Indiveri F, Pellegrino MA, Ferrone S. Effect of polyclonal and monoclonal HLA-DR xenoantibodies on xenogeneic mixed lymphocyte reactions Immunogenetics. 11: 413-416. PMID 6448810 DOI: 10.1007/BF01567808  0.44
1980 Curry RA, Pellegrino MA, Saxton RE, Jensen F, Ferrone S. Appearance of receptors for Macaca speciosa red blood cells on human fibroblasts transformed by simian virus 40 Journal of Immunology. 125: 2017-2019. PMID 6253561  0.44
1980 Callahan GN, Pellegrino MA, Ferrone S. Cross-reacting xenoantibodies to the heavy chain of H-2 and HLA-A,B antigens: Serologic and immunochemical characterization Scandinavian Journal of Immunology. 12: 297-302. PMID 6162196  0.44
1980 Indiveri F, Ng AK, Russo C, Quaranta V, Pellegrino MA, Ferrone S. Isolation of Ia-like antigen-bearing cells from human peripheral lymphocytes through the use of a monoclonal antibody to framework determinants of Ia-like antigens Journal of Immunological Methods. 39: 343-354. PMID 6161968 DOI: 10.1016/0022-1759(80)90234-3  0.44
1980 McCabe RP, Indiveri F, Galloway DR, Ferrone S, Reisfeld RA. Lack of association of serologically detectable human melanoma-associated antigens with beta 2 microglobulin: Serologic and immunochemical evidence Journal of the National Cancer Institute. 65: 703-707. PMID 6158590  0.44
1980 Quaranta V, Walker LE, Pellegrino MA, Ferrone S. Purification of immunologically functional subsets of human Ia-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent Journal of Immunology. 125: 1421-1425. PMID 6157732  0.44
1980 Belvedere M, Pellegrino MA, Ferrone S. Xenoantisera to DRw allospecificities Journal of Immunogenetics. 7: 167-172. PMID 6155413  0.44
1980 Messner RP, De Horatius R, Ferrone S. Lymphocytotoxic antibodies in systemic lupus erythematosus patients and their relatives. Reactivity with the HLA antigenic molecular complex Arthritis and Rheumatism. 23: 265-272. PMID 6153898  0.44
1980 Silver J, Ferrone S. Molecular polymorphism of HLA-DR antigens isolated from Raji and Daudi lymphoblastoid cell lines Immunogenetics. 10: 295-298. DOI: 10.1007/BF01561577  0.44
1979 Silver J, Ferrone S. Structural organization of human DR antigens and their murine analog, I-E antigens: Serologic, genetic, and functional implications Transplantation Proceedings. 11: 1743-1744. PMID 531927  0.44
1979 Pellegrino MA, Wilson BS, Ferrone S. Immunogenicity of HLA-A,B antigens expressed by human melanoma-murine fibroblast cell hybrids Transplantation Proceedings. 11: 1706-1709. PMID 531923  0.44
1979 Curry RA, Quaranta V, Pellegrino MA, Ferrone S. Serologically detectable human melanoma-associated antigens are not genetically linked to HLA-A and B antigens Journal of Immunology. 122: 2630-2632. PMID 448138  0.44
1979 Silver J, Walker LE, Reisfeld RA, Pellegrino MA, Ferrone S. Structural studies of murine I-E and human DR antigens Molecular Immunology. 16: 37-42. PMID 447368 DOI: 10.1016/0161-5890(79)90025-7  0.44
1979 Wilson BS, Indiveri F, Pellegrino MA, Ferrone S. DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization Journal of Experimental Medicine. 149: 658-668. PMID 429961  0.44
1979 Wilson BS, Indiveri F, Pellegrino MA, Ferrone S. Absence of DR antigens on human T lymphoid cells: Serologic and immunochemical studies with xenoantisera Transplantation Proceedings. 11: 712-714. PMID 377706  0.44
1979 Wilson BS, Indiveri F, Pellegrino MA, Ferrone S. Production and characterization of DR xenoantisera: use for detection of serum DR antigens Journal of Immunology. 122: 1967-1971. PMID 376728  0.44
1979 Indiveri F, Pellegrino MA, Molinaro GA, Quaranta V, Ferrone S. Rosetting of human T lymphocytes with goat red blood cells: Effect of treatment with 2-aminoethylisothiouronium bromide (AET) and comparison with AET treated sheep red blood cells Journal of Immunological Methods. 30: 317-328. PMID 315972 DOI: 10.1016/0022-1759(79)90014-0  0.44
1979 McCabe RP, Quaranta V, Frugis L, Ferrone S, Reisfeld RA. A radioimmunometric antibody-binding assay for evaluation of xenoantisera to melanoma-associated antigens Journal of the National Cancer Institute. 62: 455-463. PMID 283276 DOI: 10.1093/jnci/62.3.455  0.44
1979 Molinaro GA, Quaranta V, Ferrone S. Characterization of the specificity of DR monoclonal antibodies Transplantation Proceedings. 11: 1748-1750. PMID 93799  0.44
1979 Glassy MC, Pellegrino MA, Quaranta V, Molinaro GA, Ferrone S. Lack of DR antigens on human B-lymphocyte-mouse fibroblast hybrids that express HLA-A,B antigens Transplantation Proceedings. 11: 1719-1721. PMID 93795  0.44
1979 Richiardi P, Pellegrino M, Ferrone S. Xenoantisera to allotypic specificities of hla and b antigens: Serological characterization serological characterzation Transplantation. 28: 333-338. PMID 92080  0.44
1979 Silver J, Ferrone S. Structural polymorphism of human DR antigens [22] Nature. 279: 436-437. DOI: 10.1038/279436a0  0.44
1978 Allison JP, Ferrone S, Walker LE, Pellegrino MA, Silver J, Reisfeld RA. Partial amino acid sequence of HLA‐A9 antigen purified with a specific xenoantiserum Transplantation. 26: 451-453. PMID 569916  0.44
1978 Pellegrino MA, Ferrone S. Receptors for sheep red blood cells on human B lymphoid WI-L2 cells Clinical Immunology and Immunopathology. 9: 277-286. PMID 414871 DOI: 10.1016/0090-1229(78)90099-5  0.44
1978 Wilson BS, Pellegrino MA, Reisfeld RA, Ferrone S. A simple method for production of specific xenoantisera to human histocompatibility (HLA-A,-B,-C) antigens Transplantation Proceedings. 10: 741-743. PMID 366831  0.44
1978 Strong DM, Pellegrino MA, Ferrone S. Human lymphoid cell lines as targets for DRw In Vitro. 14: 989-995. PMID 310802 DOI: 10.1007/BF02616212  0.44
1978 Saxton RE, Irie RF, Ferrone S, Pellegrino MA, Morton DL. Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patients International Journal of Cancer. 21: 299-306. PMID 204583  0.44
1978 Ferrone S, Allison JP, Pellegrino MA. Human DR (Ia-like) antigens: biological and molecular profile Contemporary Topics in Molecular Immunology. 7: 239-281. PMID 103685  0.44
1978 Allison JP, Walker LE, Russell WA, Pellegrino MA, Ferrone S, Reisfeld RA, Frelinger JA, Silver J. Murine Ia and human DR antigens. Homology of amino-terminal sequences Proceedings of the National Academy of Sciences of the United States of America. 75: 3953-3956. PMID 99745  0.44
1978 Ferrone S. The major portion of rabbit antibody to serum HLA-A9 antigens is directed to allospecificity Tissue Antigens. 12: 153-155. PMID 81540  0.44
1978 Ferrone S, Belvedere M, Pellegrino MA. Structural relationship between W4/W6 antigens and other surface markers on cultured human lymphoid cells as determined by the 'lysostrip' method Immunogenetics. 6: 161-169. DOI: 10.1007/BF01563906  0.44
1977 Ferrone S. Rabbit complement in the lymphocytotoxicity test Tissue Antigens. 9: 223-226. PMID 877952  0.44
1977 Ferrone S, Pellegrino MA, Mittal KK. Cytotoxic antibodies to cultured human lymphoid cells in polytransfused thrombocytopenic patients: association with reduced survival of allogeneic transfused platelets Immunological Communications. 6: 267-282. PMID 142066 DOI: 10.3109/08820137709050797  0.44
1977 Ferrone S, Pellegrino MA, van Rood JJ, van Leeuwen A. Functional properties of anti-B-cell antigen alloantisera Transplantation Proceedings. 9: 675-678. PMID 141136  0.44
1977 Ferrone S, Pellegrino MA, Reisfeld RA. Immunogenicity of human B cell antigens solubilized from cultured human lymphoid cells Journal of Immunology. 118: 1036-1041. PMID 139444  0.44
1977 Ferrone S, Halasz NA, Collins G, Pellegrino MA. Humoral immunity in kidney transplant recipients. Transplantation. 23: 113-8. PMID 138228  0.44
1977 Ferrone S. Xenoantisera to allospecificities of human histocompatibility antigenic systems Transplantation. 24: 387-388. PMID 72441  0.44
1977 Thompson JS, Severson CD, Greazel NA, Ferrone S. Detection of HLA (Ia) and non-HLA specificities by "B-cell" antisera Transplantation Proceedings. 9: 597-600. PMID 68591  0.44
1977 Ferrone S, Pellegrino MA. Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients Journal of the National Cancer Institute. 58: 1201-1204. PMID 67208 DOI: 10.1093/jnci/58.5.1201  0.44
1977 Reisfeld RA, Pellegrino MA, Ferrone S. The immunologic and molecular profiles of HLA antigens isolated from urine Journal of Immunology. 118: 264-269. PMID 63518  0.44
1976 Ferrone S, Mittal KK, Pellegrino MA. Natural Antibodies to Human Lymphocytes in Murine Strains Journal of the National Cancer Institute. 56: 75-78. PMID 1255752 DOI: 10.1093/jnci/56.1.75  0.44
1976 Pellegrino MA, Ferrone S, Pellegrino AG. Inhibition of T Lymphocyte Rosetting by HL-A Alloantisera and Complement Proceedings of the Society For Experimental Biology and Medicine. 151: 321-325. PMID 1082598 DOI: 10.3181/00379727-151-39201  0.44
1976 Pellegrino MA, Ferrone S, Theofilopoulos AN. Isolation of human T and B lymphocytes by rosette formation with 2-aminoethylisothiouronium bromide (AET) - Treated sheep red blood cells and with monkey red blood cells Journal of Immunological Methods. 11: 273-279. PMID 819587 DOI: 10.1016/0022-1759(76)90120-4  0.44
1976 Pellegrino MA, Ferrone S, Reisfeld RA. Receptors for complement components and xenogeneic erythrocytes on human T- and B-lymphoid cells La Ricerca in Clinica E in Laboratorio. 6: 99-110. PMID 798257 DOI: 10.1007/BF02949080  0.44
1976 Ferrone S, Pellegrino MA, Cooper NR. Expression of C4 on human lymphoid cells and possible involvement in immune recognition phenomena. Science (New York, N.Y.). 193: 53-5. PMID 132701  0.44
1976 Ferrone S, Pellegrino MA, Reisfeld RA. The major histocompatibility complex in man: biological and molecular approaches Progress in Allergy. 114-177. PMID 63954  0.44
1976 Ferrone S, Pellegrino MA, Cooper NR. Cell line identification [5] Science. 194: 480.  0.44
1975 Pellegrino MA, Ferrone S, Theofilopoulos AN. Rosette formation of human lymphoid cells with monkey red blood cells Journal of Immunology. 115: 1065-1071. PMID 809506  0.44
1975 Ferrone S, Pellegrino MA, Callahan GN. Activation of the complement system by H-2 alloantisera: Differential susceptibility to lysis of thymocytes and lymphocytes Immunogenetics. 2: 199-203. DOI: 10.1007/BF01572287  0.44
1974 Ferrone S. Leucocyte cytotoxic isoantibodies after massive transfusion for open heart surgery Bollettino Dell'Istituto Sieroterapico Milanese. 50: 3-5. PMID 4812964  0.44
1974 Ferrone S, Polli EE. Cell growth cycle and expression of histocompatibility antigens on cultured human lymphoid cells Haematologica. 59: 25-37. PMID 4212983  0.44
1974 Poulik MD, Ferrone S, Pellegrino MA. Association of HL A antigens and β2 microglobulin: concepts and questions Transplant.Rev.. 106-125. PMID 4139784  0.44
1973 Ferrone S, Pellegrino MA. HL-A antigens, antibody, and complement in the lymphocytotoxic reaction Contemporary Topics in Molecular Immunology. 2: 185-235. PMID 4589160  0.44
1973 Brautbar C, Stanbridge EJ, Pellegrino MA, Ferrone S, Reisfeld RA, Payne R, Hayflick L. Expression of HL A antigens on cultured human fibroblasts infected with mycoplasmas Journal of Immunology. 111: 1783-1789. PMID 4127300  0.44
1972 Götze D, Ferrone S. A rapid micromethod for direct H-2 typing of mouse cultured lymphoid cells Journal of Immunological Methods. 1: 203-206. PMID 5079999 DOI: 10.1016/0022-1759(72)90047-6  0.44
1972 Pellegrino MA, Ferrone S, Pellegrino A. A Simple Microabsorption Technique for HL-A Typing Proceedings of the Society For Experimental Biology and Medicine. 139: 484-488. PMID 5059037 DOI: 10.3181/00379727-139-36169  0.44
1972 Sirchia G, Ferrone S. The laboratory substitutes of the red cell of paroxysmal nocturnal haemoglobinuria (PNH): PNH-like red cells Series Haematologica. 5: 137-175. PMID 4565711  0.44
1972 Götze D, Ferrone S, Reisfeld RA. Serologic cross-reactivity between H-2 and HL-A antigens. I. Specific reactivity of rabbit anti-HL-A sera against murine cells Journal of Immunology. 109: 439-450. PMID 4115540  0.44
1972 Ferrone S, Pellegrino MA, Reisfeld RA. TYPING OF CULTURED HUMAN LYMPHOID CELLS The Lancet. 299: 1237-1238. PMID 4113220 DOI: 10.1016/S0140-6736(72)90957-9  0.44
1971 Sirchia G, Ferrone S, Mercuriali F. Leukocyte antigens and histocompatibility Il Policlinico. Sezione Pratica. 78: 315-331. PMID 5570191  0.44
1971 Ferrone S, Pellegrino MA, Reisfeld RA. A rapid method for direct HL-A typing of cultured lymphoid cells Journal of Immunology. 107: 613-615. PMID 5568777  0.44
1971 Sirchia G, Ferrone S. Normal human lymphocytes treated in vitro with the sulfhydryl compound AET: relationship to the lymphocytes of paroxysmal nocturnal hemoglobinuria Blood. 37: 563-567. PMID 5554214  0.44
1971 Ferrone S, Mercuriali F, Scalamogna M. Cephalothin positive direct coombs test. Relationship to serum immunoglobulin concentration Experientia. 27: 193-194. PMID 5544746 DOI: 10.1007/BF02145890  0.44
1971 Lewis SM, Lambertenghi G, Ferrone S, Sirchia G. Electron microscope study of PNH red cells and AET-treated normal red cells (PNH-like cells) Journal of Clinical Pathology. 24: 677-684. PMID 5130532  0.44
1971 Ferrone S, Zanella A, Scalamogna M. Red cell metabolism in positive direct coombs test after cephalothin therapy Experientia. 27: 194-195. PMID 5101648 DOI: 10.1007/BF02145891  0.44
1971 Ferrone S, Lambertenghi-Deliliers G, Ranzi T. Normal human red cells treated in vitro with cephalothin. A scanning electron microscope study Acta Haematologica. 45: 245-249. PMID 4999132  0.44
1970 Ferrone S, Zanella A, Sirchia G. Enzymatic and metabolic activities of erythrocytes in paroxysmal nocturnal hemoglobinuria Acta Vitaminologica Et Enzymologica. 24: 237-263. PMID 5537938  0.44
1970 Ferrone S, Zanella A, Sirchia G. Study of the acetylcholinesterase activity of AET-treated (2-aminoethylisothiouronium bromide) normal red cells (PNH-like cells) Acta Vitaminologica Et Enzymologica. 24: 222-225. PMID 5537936  0.44
1970 Sirchia G, Ferrone S, Zanella A. Determination of red cell acetylcholinesterase activity by diagnostic kit; modification of the method Acta Vitaminologica Et Enzymologica. 24: 219-221. PMID 5537935  0.44
1970 Ferrone S, Zanella A, Sirchia G. Erythrocyte glutathione reductase activity in chronic renal disease Scandinavian Journal of Haematology. 7: 409-412. PMID 5507564  0.44
1970 Sirchia G, Ferrone S, Mercuriali F. Leukocyte antigen-antibody reaction and lysis of paroxysmal nocturnal hemoglobinuria erythrocytes Blood. 36: 334-336. PMID 5311198  0.44
1970 Lambertenghi G, Ferrone S, Sirchia G. Surface ultramicroscopy of paroxysmal nocturnal haemoglobinuria erythrocytes Acta Haematologica. 44: 257-264. PMID 4994888 DOI: 10.1159/000208690  0.44
1970 Sirchia G, Ferrone S, Mercuriali F. PREVENTION OF LEUCOCYTE-ANTIBODY FORMATION The Lancet. 295: 898. PMID 4191544 DOI: 10.1016/S0140-6736(70)91730-7  0.44
1969 Sirchia G, Ferrone S, Mercuriali F. In-vitro lysis of AET-treated normal red cells (PNH-like cells) by normal and cirrhotic sera British Journal of Haematology. 17: 245-249. PMID 4979897  0.44
1969 Sirchia G, Ferrone S, Mercuriali F. The in vitro lysis of the red cells of paroxysmal nocturnal haemoglobinuria by the serum of patients with cirrhosis of the liver British Journal of Haematology. 16: 269-275. PMID 4978548  0.44
1969 Ferrone S, Mercuriali F, Sirchia G. The positive direct coombs test of cephalothin-treated blood Experientia. 25: 78-79. PMID 4179729 DOI: 10.1007/BF01903909  0.44
1968 Sirchia G, Ferrone S, Mercuriali F. Determination of erythrocyte acetylcholinesterase by the dithiobisnitrobenzoic acid method, carried out with ready made reagents Haematologica Latina. 11: 383-386. PMID 5736508  0.44
1968 Ferrone S, Mercuriali F, Farina C. Paroxysmal nocturnal hemoglobinuria and paroxysmal "cold" hemoglobinuria. Comparative study on the kinetics of the hemolysis Haematologica Latina. 11: 61-69. PMID 5722010  0.44
1968 Ferrone S, Mercuriali F, Zanella A. Action of cephalothin on the blood "in vitro": influence of some plasmatic components on the sensitivity of the erythrocytes to the drug Giornale Di Clinica Medica. 49: 870-884. PMID 5716825  0.44
1968 Ferrone S, Sirchia G. Survival of Cephalothin-Treated Erythrocytes Jama: the Journal of the American Medical Association. 206: 378. PMID 5695620 DOI: 10.1001/jama.1968.03150020094034  0.44
1968 Sirchia G, Mercuriali F, Ferrone S. Cephalothin-treated normal red cells: A new type of PNH-like cells Experientia. 24: 495-496. PMID 5674999 DOI: 10.1007/BF02144414  0.44
1968 Ferrone S, Zanella A, Sirchia G. Red cell acetylcholinesterase in ABO haemolytic disease of the newborn Experientia. 24: 495. PMID 4970753 DOI: 10.1007/BF02144413  0.44
1966 Sirchia G, Ferrone S, Nocca G. Some red cell enzyme activities in paroxysmal nocturnal haemoglobinuria Enzymologia Biologica Et Clinica. 7: 145-148. PMID 5965865  0.44
1966 Praga C, Jean G, Ferrone S. Effect of 2-amino-ethylisothiouronium bromide (AET) on blood coagulation Thrombosis Et Diathesis Haemorrhagica. 15: 131-142. PMID 5919797  0.44
1966 Ferrone S, Zanella A, Sirchia G. Normal human red cells treated with 2-aminoethylisothiouroniumbromide (AET). Acetylcholinesterase inactivation and susceptibility to acid lysis in vitro Experientia. 22: 731-732. DOI: 10.1007/BF01901346  0.44
1965 Sirchia G, Ferrone S, Zanella A. Normal human erythrocytes treated with sulfhydryl compounds. Study of the kinetics of hemolysis and of the hemolytic system in relation to the erythrocytes of nocturnal paroxysmal hemoglobinuria Haematologica Latina. 8: 53-63. PMID 5867150  0.44
1965 Sirchia G, Ferrone S, Mercuriali F. A case of paroxysmal cold haemoglobinuria with unusual serological findings Haematologica Latina. 8: 103-112. PMID 5861585  0.44
Show low-probability matches.